Crossmark

Correction to: Effectiveness of chlorthalidone/amiloride versus losartan in patients with stage I hypertension and diabetes mellitus: results from the PREVER-treatment randomized controlled trial

Crossref DOI link: https://doi.org/10.1007/s00592-021-01689-8

Published Online: 2021-03-01

Published Print: 2021-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fuchs, Flávio D.

Scala, Luiz C. N.

Vilela-Martin, José F.

Whelton, Paul K.

Poli-de-Figueiredo, Carlos E.

Pereira E Silva, Ricardo

Gus, Miguel

Bortolotto, Luiz A.

Consolim-Colombo, Fernanda M.

Schlatter, Rosane P.

Cesarino, Evandro J.

Castro, Iran

Figueiredo Neto, José A.

Chaves, Hilton

Steffens, André A.

Alves, João G.

Brandão, Andréa A.

de Sousa, Marcos R.

Jardim, Paulo C.

Moreira, Leila B.

Franco, Roberto S.

Gomes, Marco M.

Afiune Neto, Abrahão

Fuchs, Felipe C.

Sobral Filho, Dario C.

Nóbrega, Antônio C.

Nobre, Fernando

Berwanger, Otávio

Fuchs, Sandra C. https://orcid.org/0000-0001-6351-9588
License Information

Text and Data Mining valid from 2021-03-01

Version of Record valid from 2021-03-01
More Information

Article History

First Online: 1 March 2021

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below